• 1
    Godfrey, D. I. and Kronenberg, M., Going both ways: immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 2004. 114: 13791388.
  • 2
    Sandberg, J. K. and Ljunggren, H. G., Development and function of CD1d-restricted NKT cells: influence of sphingolipids, SAP and sex. Trends Immunol. 2005. 26: 347349.
  • 3
    Fujii, S., Shimizu, K., Hemmi, H. and Steinman, R. M., Innate Valpha14+natural killer T cells mature dendritic cells, leading to strong adaptive immunity. Immunol. Rev. 2007. 220: 183198.
  • 4
    Dougan, S. K., Kaser, A. and Blumberg, R. S., CD1 expression on antigen-presenting cells. Curr. Top. Microbiol. Immunol. 2007. 314: 113141.
  • 5
    Stronge, V. S., Salio, M., Jones, E. Y. and Cerundolo, V., A closer look at CD1d molecules: new horizons in studying NKT cells. Trends Immunol. 2007. 28: 455462.
  • 6
    Smed-Sorensen, A., Moll, M., Cheng, T. Y., Lore, K., Norlin, A. C., Perbeck, L., Moody, D. B. et al., IgG regulates the CD1 expression profile and lipid antigen-presenting function in human dendritic cells via FcγRIIa. Blood 2008. 111: 50375046.
  • 7
    Yamamura, T., Sakuishi, K., Illes, Z. and Miyake, S., Understanding the behavior of invariant NKT cells in autoimmune diseases. J. Neuroimmunol. 2007. 191: 815.
  • 8
    Swann, J. B., Coquet, J. M., Smyth, M. J. and Godfrey, D. I., CD1-restricted T cells and tumor immunity. Curr. Top. Microbiol. Immunol. 2007. 314: 293323.
  • 9
    Meyer, E. H., DeKruyff, R. H. and Umetsu, D. T., iNKT cells in allergic disease. Curr. Top. Microbiol. Immunol. 2007. 314: 269291.
  • 10
    Tupin, E., Kinjo, Y. and Kronenberg, M., The unique role of natural killer T cells in the response to microorganisms. Nat. Rev. Microbiol. 2007. 5: 405417.
  • 11
    Motsinger, A., Haas, D. W., Stanic, A. K., Van Kaer, L., Joyce, S. and Unutmaz, D., CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection. J. Exp. Med. 2002. 195: 869879.
  • 12
    van der Vliet, H. J., von Blomberg, B. M., Hazenberg, M. D., Nishi, N., Otto, S. A., van Benthem, B. H., Prins, M. et al., Selective decrease in circulating Vα24+Vβ11+NKT cells during HIV type 1 infection. J. Immunol. 2002. 168: 14901495.
  • 13
    Sandberg, J. K., Fast, N. M., Palacios, E. H., Fennelly, G., Dobroszycki, J., Palumbo, P., Wiznia, A. et al., Selective loss of innate CD4+Vα24 natural killer T cells in human immunodeficiency virus infection. J. Virol. 2002. 76: 75287534.
  • 14
    Giorgi, J. V., Hultin, L. E., McKeating, J. A., Johnson, T. D., Owens, B., Jacobson, L. P., Shih, R. et al., Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J. Infect. Dis. 1999. 179: 859870.
  • 15
    Hazenberg, M. D., Stuart, J. W., Otto, S. A., Borleffs, J. C., Boucher, C. A., de Boer, R. J., Miedema, F. and Hamann, D., T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood 2000. 95: 249255.
  • 16
    Hellerstein, M., Hanley, M. B., Cesar, D., Siler, S., Papageorgopoulos, C., Wieder, E., Schmidt, D. et al., Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat. Med. 1999. 5: 8389.
  • 17
    Lane, H. C., Masur, H., Edgar, L. C., Whalen, G., Rook, A. H. and Fauci, A. S., Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 1983. 309: 453458.
  • 18
    Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z. et al., Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 2006. 12: 13651371.
  • 19
    Kim, C. H., Johnston, B. and Butcher, E. C., Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among Vα24+Vβ11+NKT cell subsets with distinct cytokine-producing capacity. Blood 2002. 100: 1116.
  • 20
    Thedrez, A., de Lalla, C., Allain, S., Zaccagnino, L., Sidobre, S., Garavaglia, C., Borsellino, G. et al., CD4 engagement by CD1d potentiates activation of CD4+invariant NKT cells. Blood 2007. 110: 251258.
  • 21
    Chen, X., Wang, X., Besra, G. S. and Gumperz, J. E., Modulation of CD1d-restricted NKT cell responses by CD4. J. Leukoc. Biol. 2007. 82: 14551465.
  • 22
    Gumperz, J. E., Miyake, S., Yamamura, T. and Brenner, M. B., Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 2002. 195: 625636.
  • 23
    Lee, P. T., Benlagha, K., Teyton, L. and Bendelac, A., Distinct functional lineages of human Vα24 natural killer T cells. J. Exp. Med. 2002. 195: 637641.
  • 24
    Sandberg, J. K., Stoddart, C. A., Brilot, F., Jordan, K. A. and Nixon, D. F., Development of innate CD4+alpha-chain variable gene segment 24 (Vα24) natural killer T cells in the early human fetal thymus is regulated by IL-7. Proc. Natl. Acad. Sci. USA 2004. 101: 70587063.
  • 25
    Yang, O. O., Wilson, S. B., Hultin, L. E., Detels, R., Hultin, P. M., Ibarrondo, F. J. and Jamieson, B. D., Delayed reconstitution of CD4+iNKT cells after effective HIV type 1 therapy. AIDS Res. Hum. Retroviruses 2007. 23: 913922.
  • 26
    Moll, M., Snyder-Cappione, J., Spotts, G., Hecht, F. M., Sandberg, J. K. and Nixon, D. F., Expansion of CD1d-restricted NKT cells in patients with primary HIV-1 infection treated with interleukin-2. Blood 2006. 107: 30813083.
  • 27
    Vasan, S., Poles, M. A., Horowitz, A., Siladji, E. E., Markowitz, M. and Tsuji, M., Function of NKT cells, potential anti-HIV effector cells, are improved by beginning HAART during acute HIV-1 infection. Int. Immunol. 2007. 19: 943951.
  • 28
    van der Vliet, H. J., van Vonderen, M. G., Molling, J. W., Bontkes, H. J., Reijm, M., Reiss, P., van Agtmael, M. A. et al., Cutting edge: rapid recovery of NKT cells upon institution of highly active antiretroviral therapy for HIV-1 infection. J. Immunol. 2006. 177: 57755778.
  • 29
    Keir, M. E., Butte, M. J., Freeman, G. J. and Sharpe, A. H., PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 2008. 26: 677704.
  • 30
    van Der Vliet, H. J., Nishi, N., de Gruijl, T. D., von Blomberg, B. M., van den Eertwegh, A. J., Pinedo, H. M., Giaccone, G. and Scheper, R. J., Human natural killer T cells acquire a memory-activated phenotype before birth. Blood 2000. 95: 24402442.
  • 31
    Gonzalez, V. D., Falconer, K., Michaelsson, J., Moll, M., Reichard, O., Alaeus, A. and Sandberg, J. K., Expansion of CD56- NK cells in chronic HCV/HIV-1 co-infection: reversion by antiviral treatment with pegylated IFNα and ribavirin. Clin. Immunol. 2008. 128: 4656.
  • 32
    Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W. et al., PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006. 443: 350354.
  • 33
    Trautmann, L., Janbazian, L., Chomont, N., Said, E. A., Gimmig, S., Bessette, B., Boulassel, M. R. et al., Upregulation of PD-1 expression on HIV-specific CD8+T cells leads to reversible immune dysfunction. Nat. Med. 2006. 12: 11981202.
  • 34
    Petrovas, C., Casazza, J. P., Brenchley, J. M., Price, D. A., Gostick, E., Adams, W. C., Precopio, M. L. et al., PD-1 is a regulator of virus-specific CD8+T cell survival in HIV infection. J. Exp. Med. 2006. 203: 22812292.
  • 35
    Zhang, J. Y., Zhang, Z., Wang, X., Fu, J. L., Yao, J., Jiao, Y., Chen, L. et al., PD-1 up-regulation is correlated with HIV-specific memory CD8+T-cell exhaustion in typical progressors but not in long-term nonprogressors. Blood 2007. 109: 46714678.
  • 36
    Montoya, C. J., Catano, J. C., Ramirez, Z., Rugeles, M. T., Wilson, S. B. and Landay, A. L., Invariant NKT cells from HIV-1 or Mycobacterium tuberculosis-infected patients express an activated phenotype. Clin. Immunol. 2008. 127: 16.
  • 37
    Cho, S., Knox, K. S., Kohli, L. M., He, J. J., Exley, M. A., Wilson, S. B. and Brutkiewicz, R. R., Impaired cell surface expression of human CD1d by the formation of an HIV-1 Nef/CD1d complex. Virology 2005. 337: 242252.
  • 38
    Chen, N., McCarthy, C., Drakesmith, H., Li, D., Cerundolo, V., McMichael, A. J., Screaton, G. R. and Xu, X. N., HIV-1 down-regulates the expression of CD1d via Nef. Eur. J. Immunol. 2006. 36: 278286.
  • 39
    Riley, J. L. and June, C. H., The road to recovery: translating PD-1 biology into clinical benefit. Trends Immunol. 2007. 28: 4850.
  • 40
    Gonzalez, V. D., Bjorkstrom, N. K., Malmberg, K. J., Moll, M., Kuylenstierna, C., Michaelsson, J., Ljunggren, H. G. and Sandberg, J. K., Application of nine-color flow cytometry for detailed studies of the phenotypic complexity and functional heterogeneity of human lymphocyte subsets. J. Immunol. Methods 2008. 330: 6474.
  • 41
    Sandberg, J. K., Bhardwaj, N. and Nixon, D. F., Dominant effector memory characteristics, capacity for dynamic adaptive expansion, and sex bias in the innate Vα24 NKT cell compartment. Eur. J. Immunol. 2003. 33: 588596.